FIG. 5.
Increase in SLU by the fnbB-luxAB reporter plasmid in strain EN1252a(pFNBB6) or ISP794(pFNBB6) exposed for 20 min to either control MHB or MHB supplemented with rifampin (2 μg/ml), with one-quarter the MIC (8 μg/ml) of ciprofloxacin, or with rifampin (2 μg/ml) followed by ciprofloxacin (8 μg/ml).